Why the study?
LQTS poses significant anesthetic management challenges due to the potential to provoke life-threatening arrhythmias like Torsades de Pointes and sudden cardiac death.
What are the optimal anesthetic management strategies for patients with Long QT syndrome to prevent life-threatening arrhythmias?
What are the optimal anesthetic management strategies for patients with Long QT syndrome to prevent life-threatening arrhythmias?
This review provides a comprehensive framework for the safe anesthetic management of patients with Long QT syndrome, emphasizing the avoidance of QT-prolonging agents and meticulous perioperative monitoring.
Answers are grounded in this paper and cite their sources.
Anesthetic management strategies for LQTS remain incompletely validated; this review leaves open the need for prospective trials.
Long QT syndrome (LQTS) poses significant challenges in anesthetic management due to its potential to provoke life-threatening arrhythmias such as Torsades de Pointes, which can lead to sudden cardiac death if not properly managed. This review examines the pathophysiology of LQTS, its classification into congenital and acquired forms, and the associated anesthetic risks, while providing evidence-based strategies for its safe and effective management. Congenital LQTS is subdivided into LQT1, LQT2, and LQT3, each associated with distinct genetic mutations, ion channel dysfunctions, and specific triggers, whereas acquired LQTS arises from factors such as drug-induced effects, electrolyte imbalances, and underlying medical conditions. Accurate diagnosis hinges on a thorough clinical evaluation, electrocardiogram findings, and, where applicable, genetic testing to guide individualized risk stratification and tailored management plans. Anesthetic management in LQTS demands meticulous planning, vigilance, and a comprehensive understanding of the syndrome’s complexities. Preoperative strategies focus on optimizing electrolyte levels, discontinuing QT-prolonging medications, and assessing genetic predispositions that may exacerbate risks. The intraoperative phase requires continuous ECG monitoring to detect QT prolongation, the judicious selection of anesthetic drugs to minimize arrhythmogenic potential, and readiness to address arrhythmic events with therapies such as intravenous magnesium sulfate and immediate defibrillation. Postoperative care emphasizes extended monitoring, strict maintenance of electrolyte balance, and the avoidance of QT-prolonging agents to reduce the risk of delayed complications. This review underscores the importance of a multidisciplinary approach, involving anesthesiologists, cardiologists, and geneticists, in delivering optimal care to patients with LQTS. By focusing on detailed preoperative assessment, careful drug selection, and proactive intra- and postoperative management, clinicians can effectively minimize risks and enhance patient safety. These recommendations provide a robust framework for navigating the challenges of anesthesia in individuals with LQTS.
No takes yet. Share an insight, caveat, or question.
Dhanure et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: